Public Article
-
verified
Pharmacologic Advancement in Schizophrenia
ISSN: 2617 - 9482Publisher: author   
Pharmacologic Advancement in Schizophrenia
Indexed in
Health Sciences
ARTICLE-FACTOR
1.3
Article Basics Score: 3
Article Transparency Score: 2
Article Operation Score: 2
Article Articles Score: 2
Article Accessibility Score: 3
SUBMIT PAPER ASK QUESTION
International Category Code (ICC):
ICC-0702
Publisher: Bahria University Medical And Dental College
International Journal Address (IAA):
IAA.ZONE/261797539482
eISSN
:
2617 - 9482
VALID
ISSN Validator
Abstract
Schizophrenia is a disorder of mental debility characterized by abnormal social behavior in which person is unable torecognize reality. The sign and symptoms are variable and heterogeneous. Due to the diverse symptoms and variabletreatment response, it is challenging to treat. Recent advancements in genomic, epidemiology and neurosciences canprovide the appropriate medicines and treatments for minimizing symptoms and consequences of schizophrenia. Thisliterature review was highlights the etiology, pathophysiology, neurotransmitter system, novel treatment and managementof schizophrenia.The mainstay treatment of schizophrenic patients included antipsychotic drug with psychotherapy, socialrehabilitation and job training.